Until now, the cause of PD is unknown, but several factors seem to play a role, including environmental factors, such as the pesticide rotenone, that can block mitochondrial functions
It suits patients continuing an established treatment plan or seeking stronger results than the 600mg dose
They offer a holistic approach to maintaining a youthful appearance while also promoting internal health
Still, insurance coverage and cost considerations mean both drugs remain relevant, and patient-centred conversations about therapy choice are critical. GLP-1s beyond weight loss as multi-system therapies Liver disease and metabolic steatohepatitis Non-alcoholic fatty liver disease (NAFLD) and the more severe metabolic dysfunction-associated steatohepatitis (MASH) have few effective pharmacologic treatments
Treatments with DSIP and DSIP-CBBBP are shown to effectively increase melatonin levels, indicating a stress-mitigating potential, whereas CBBBP treatment alone does not significantly affect melatonin levels, pointing to its limited efficacy in this context
